Thompson Davis & Co’s Inogen INGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
$31K Hold
125
– – 0.07% 273
2018
Q2
$23K Hold
125
– – 0.05% 291
2018
Q1
$15K Hold
125
– – 0.04% 338
2017
Q4
$15K Hold
125
– – 0.04% 357
2017
Q3
$12K Hold
125
– – 0.02% 634
2017
Q2
$12K Hold
125
– – 0.02% 606
2017
Q1
$10K Hold
125
– – 0.01% 687
2016
Q4
$8K Hold
125
– – 0.01% 749
2016
Q3
$7K Hold
125
– – 0.01% 750
2016
Q2
$6K Hold
125
– – 0.01% 754
2016
Q1
$6K Sell
125
-625
-83% -$22.3K 0.01% 746
2015
Q4
$30K Buy
+750
New +$31.7K 0.04% 352

Other funds holding INGN

Thompson Davis & Co's INGN Position: Q3 2018 in Review

Thompson Davis & Co held its Inogen (INGN) position steady in Q3 2018 at 125 shares worth $31K. The position accounts for 0.07% of the portfolio, ranked #273.

Thompson Davis & Co first reported a position in INGN in Q4 2015 and has held it in 12 quarters since. 282 funds tracked by Wall St. Rank hold INGN as of Q3 2018.

  • Thompson Davis & Co held 125 shares of Inogen worth $31K as of Q3 2018.
  • Thompson Davis & Co left its Inogen share count unchanged in Q3 2018.
  • Inogen made up 0.07% of Thompson Davis & Co's portfolio in Q3 2018, its #273 holding.
  • Thompson Davis & Co first reported a position in Inogen in Q4 2015 and has held it in 12 quarters since.
  • 282 funds tracked by Wall St. Rank held Inogen as of Q3 2018.

Based on Thompson Davis & Co's 13F filing for Q3 2018, filed 14 Nov 2018.